Clinical Trial Update: Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast Cancer

View source ↗

Summary

Trial update on the efficacy of a neoadjuvant subcutaneous trastuzumab-pertuzumab regimen in Algerian women with non-metastatic HER2-positive locally advanced b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Blida 1 University | Conditions: Non Metastatic HER2 Positive Breast Cancer | Status: RECRUITING